Security key
G72245106
- Security type / class
- Equity / Stock
- Total 13F shares
- 25
- Total 13F value
- $483
- Share change
- 0
- SEC-reported price per share
- $19.32
- Number of holders
- 1
Report period
Q1 2026
Institutions
1
Top holders
1
PRE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Prenetics Global Ltd SEC filings
Prenetics Global Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G72245106
Recent filing periods:
Ownership snapshot
Top reported holders of PRE - PRENETICS GLOBAL LTD SHS NEW - Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EASTSPRING INVESTMENTS (S...
Disclosed value leader
Genetel Bioventures Ltd
Comparable rows
2/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 3.8%
13 rows are not safely comparable across share classes.
13D/G row: EASTSPRING INVESTMENTS (SINGAPORE) LTD
Showing 1-6 of 15 holder rows.
Quick read
EASTSPRING INVESTMENTS (SINGAPORE) LTD leads the comparable SEC ownership view at 3.8%.
2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EASTSPRING INVESTMENTS (SINGAPORE) LTD's linked filing trail.
Comparable ownership
Top 2
EASTSPRING INVESTMENTS (SINGAPORE...
3.8%
Genetel Bioventures Ltd
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EASTSPRING INVESTMENTS (SINGAPORE) LTD |
13D/G
EASTSPRING INVESTMENTS (SINGAPORE) LIMITED
|
3.8%
Reported 13D/G
· 30 Sep 2024
|
$2,225,408
427,963 shares
|
$0 | 30 Sep 2024 |
| Genetel Bioventures Ltd |
13D/G
|
3.3%
Reported 13D/G
· 31 Mar 2026
|
$9,444,962
488,857 shares
|
$0 | 31 Mar 2026 |
| PRUDENTIAL PLC |
13F
Company
|
—
denominator unverified
|
$6,740,417
427,963 shares
|
— | 31 Dec 2025 |
| Aspex Management (HK) Ltd |
13F
Company
|
—
mixed-class rows
|
$5,487,000
1,512,816 shares
mixed-class rows
|
— | 31 Dec 2025 |
| NOMURA HOLDINGS INC |
13F
Company
|
—
denominator unverified
|
$4,221,016
268,001 shares
|
— | 31 Dec 2025 |
| Da Yeung Ltd |
3/4/5
Wholly owned by Danny Yeung
|
—
mixed-class rows
|
$2,184,430
1,719,666 shares
mixed-class rows
|
— | 26 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
25
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
1
Q1 2026 holders
1
Holder diff
0
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend